Method of treating lymphoma using a combination of chemotherapeutic agent, IL-2 and optionally anti-CD20 antibody

摘要

Methods for treating B-cell lymphomas, such as non-Hodgkin's lymphoma (NHL) are disclosed. The methods use a combination therapy of a chemotherapeutic agent, an IL-2 and, optionally, an anti-CD20 antibody.